Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-15

FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (7-eleven)

View source ↗

Summary

FDA approved a supplemental application for fexofenadine hydrochloride (ANDA 202039) submitted by 7-eleven.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine hydrochloride (generic) (fexofenadine hydrochloride)

Snippet

SUPPL AP for FEXOFENADINE HYDROCHLORIDE (FEXOFENADINE HYDROCHLORIDE)